Research Article

Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response

Table 1

(a) Clinical characteristics of 11 TNBC tumors

LTQ Orbitrap sample IDPatient ageEthnicityTR %ResponseT stageHistological typeERPRFISH R/G ratioNeoadjuvant

#161White80RT3IDC 1.10TC
#229Hispanic−60NRT3IDC0.92TC
#555Hispanic100R (pCR)T3IDC0.92TC
#654Hispanic100R (pCR)T3IDC1.01TC
#740Asian45IRT3IDC1.17TC
#844White R (pCR)T3IDC1.00TC
#949Hispanic48IRT4IDC1.10TC
#1053White100R (pCR)T3IDC1.20TC
#1184Asian100R (pCR)T4IDC1.03TC
#3645Hispanic30IRT3IDC1.27TC
#3738White100R (pCR)T2IDC1.10TC

aLN positive without residual primary cancer.
(b) Clinical characteristics of 28 HER2+ tumors

LTQ Orbitrap sample IDPatient ageEthnicityTRR %ResponseT stageHistological typeERPRFISH R/G ratioNeoadjuvant

#1738White40IRT3IDC+12.4TC
#1863Asian100R (pCR)T3IDC+12.7TCH
#1957White100R (pCR)T3IDC4.6TC
#2056Asian78.2RT4IDC+10.71TC
#2151Black56IRT3IDC19.97TCH
#2231White45.5IRT3IDC++2.2TC
#2355White80RT4IDC++3.8TC
#2445Asian75IRT4IDC++2.7TCH
#2542Hispanic63.5IRT4IDC+2.5TC
#2650White67.1IRT3IDC2.41TCH
#2733White82.9RT3IDC++3.03TCH
#2840White66.7IRT3IDC8.1TC
#2935Hispanic R (pCR)T3IDC42.2TCH
#3044White97.3RT4IDC4.2TC
#3130White−7.7NRT3IDC+5TC
#3257White25%NRT4IDC+ >4TCH
#3337White33.3IRT2IDC++9.49TC
#3436Black25NRT3IDC5.1TC
#3542White60IRT2IDC++4.5TCH
#3855White42.3IRT4IDC3.9TCH
#3947White R (pCR)T3IDC + + >20TCH
#4050Asian R (pCR)T3IDC + +4.19TCH
#4158White50IRT4IDC + +2.1TCH
#4240Asian60IRT2IDC16TC
#4337White−85.6NRT3IDC + +3.1TC
#4449White R (pCR)T2IDC +7.7TCH
#4555Asian92.6RT3IDC9.9TC
#4641Hispanic100R (pCR)T2IDC9.2TC

aLN positive and residual DCIS; bresidual DCIS only.